Search

Your search keyword '"Cardinale V."' showing total 451 results

Search Constraints

Start Over You searched for: Author "Cardinale V." Remove constraint Author: "Cardinale V."
451 results on '"Cardinale V."'

Search Results

3. OC.06.2: POTENTIALOFA NATURAL COMPOUNDAS HEDGEHOG PATHWAY INHIBITOR FOR THE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA

4. OC.05.7: CHOLESTASIS IMPACTS ON PERFORMANCE OF NON INVASIVE TESTS FOR RULING OUT HIGH-RISK ESOPHAGEALVARICES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED ADVANCED CHRONIC LIVER DISEASE

6. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

8. Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis

9. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

10. Survey on hepatic sarcoidosis in Italy

11. Etiology and Outcome of Adult and Pediatric Acute Liver Failure in Europe.

12. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

14. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

15. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

16. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

17. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

18. Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis

19. Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?

20. CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study

21. Setup of multidisciplinary team discussions for patients with cholangiocarcinoma:current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

22. Bridging the equity gap in patient education: the biliary tract cancer BABEL project

23. Bridging the equity gap in patient education: the biliary tract cancer BABEL project

25. Digestive diseases. 2022-2025 edition

27. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma

28. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret

29. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

30. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

31. Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach

32. DCLK1, a putative novel stem cell marker in human cholangiocarcinoma

33. Oncogenic signaling pathways in the Cancer Genome Atlas

34. Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment

35. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

36. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis

37. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

38. CALIBRAGEM DE MODELOS PARA ESTIMATIVA DA EVAPORAÇÃO EM FUNÇÃO DO NÍVEL DO LENÇOL FREÁTICO

40. Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023))

41. Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

42. FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

44. Recommendations on the use of magnetic resonance imaging for collaborative multicenter studies in PSC

45. Liver metastases (LM) from intrahepatic cholangiocarcinoma (iCCA): Outcomes from the European Network for the study of cholangiocarcinoma (ENS-CCA) registry and implications on current American Joint Committee on Cancer (AJCC) staging

47. PC.01.6 HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES

48. Human duodenal submucosal glands contain stem cells with potential for liver and pancreatic regenerative medicine

49. Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

50. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma

Catalog

Books, media, physical & digital resources